Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Significantly downregulated proteins when adjusting for body weight effects in STEP 1 known to be associated with CVD risk included tenascin C (TNC), NT-proBNP, thrombospondin 2 (THBS2), complement component C1q receptor (cluster of differentiation 93 (CD93)), macrophage scavenger receptor 1extracellular domain (MSR1) and angiopoietin-2 (ANGPT2)
Rajeswaran FRCP(UK);MSc Consultant Physician Obesity, Diabetes & Endocrinology Dr Rajeswaran is a Consultant Physician, Specialist in Endocrinology, Diabetes and Obesity
HiActives is a trademark of VDF FutureCeuticals, Inc., used under license
Ongoing research includes clinical trials focused on evaluating the efficacy and safety of Semaglutide in various IBS subtypes, its long-term impact on gastrointestinal and metabolic health, and its interaction with the gut microbiome
